Conflicts and disclosures

Owned organisations, commercial relationships and how they are kept separate from clinical decisions

A transparent ledger of every clinic, company, lab, technology platform and charity Professor Lee has founded, directs or holds a commercial interest in, and the policy that keeps clinical suitability decisions separate from commercial framing.

Last reviewed: 2026-06-07

Section 01

Why this page exists

Professor Paul Lee has built a body of clinical, academic, research and innovation work that spans more than one organisation. Several of those organisations were founded by him, are directed by him, or have a commercial relationship with him.

That makes this site, and the wider ecosystem of partner sites, more complex than a single hospital website. This page exists so that complexity is transparent, so that visitors, peers, regulators, solicitors, journalists and clinical colleagues can see at a glance what is owned, what is independent, and how the two are kept separate when clinical decisions are made.

Section 02

How owned entities are kept separate from independent authority

Independent authority signals (General Medical Council registration, university appointments, professional society memberships, peer-elected honours, peer-reviewed publications, journal editorial roles, third-party indexes) are surfaced on /credentials-and-verification. Owned organisations are listed separately on this page, and on individual pages under /projects-and-ecosystem.

In structured data, the same separation is enforced: Professor Lee's Person and Physician graph lists only independent organisations under "worksFor", "affiliation" and "memberOf". Owned organisations appear in their own Organization records on their respective project pages, with Professor Lee referenced as their founder.

In editorial framing, clinical content (what is the appropriate next step for this patient, this joint, this stage) is written from a clinical perspective. Where the treatment being discussed is one in which Professor Lee has a commercial interest, the interest is disclosed inline on the page and consolidated here.

Section 03

Clinical services Professor Lee founded or directs

Clinics and clinical platforms where Professor Lee carries out private practice or holds an active founding-director role.

  • London Cartilage Clinic

    Founder and Founding Medical Director; ICRS Accredited Teaching Centre of Excellence host site.

    Specialist Harley Street clinic for cartilage injury, joint preservation and regenerative joint surgery.

    Visit

  • MSK Doctors

    Founder and Founding Medical Director (since 2018).

    Broader MSK clinical platform with the only dedicated musculoskeletal open MRI scanner in Lincolnshire.

    Visit

  • AMSK

    Arthrosamid joint injections for patients, available nationwide, delivered to one trained clinical standard.

    Visit

  • The Keep Clinic

    Clinical brand under Professor Lee’s ownership operating as a distinct clinical service.

    Visit

  • Lincolnshire Hip Clinic

    Local clinical service for hip treatments in Lincolnshire.

    Visit

  • Lincolnshire Knee Clinic

    Local clinical service for knee treatments in Lincolnshire.

    Visit

Section 04

Treatment and condition sites

Specialist patient-education sites for named treatments and conditions, part of the wider clinical operation Professor Lee owns.

  • Hip Replacement Lincolnshire

    Hip replacement for Lincolnshire patients using the SPAIRE approach (Spare Piriformis And Internus, Repair Externus), which preserves the deep hip rotators for faster recovery.

    Visit

  • Spairehips

    Clinical site dedicated to SPAIRE hip replacement (Spare Piriformis And Internus, Repair Externus): the posterior approach that keeps the deep rotators attached for faster real-world recovery.

    Visit

  • Liquid Cartilage

    Technique pioneered by Prof Lee at London Cartilage Clinic.

    The Liquid Cartilage Plus + ChondroFiller cartilage-repair technique, explained for patients — what it is, who it suits and how it works — from the team that pioneered it at London Cartilage Clinic.

    Visit

  • ACL.Repair

    Specialist site for ACL repair, STARR augmented repair, ligament preservation and return-to-sport pathways.

    Visit

  • Meniscus.Repair

    Repairing and preserving a torn meniscus, including augmented repair — the options explained for patients, from London Cartilage Clinic.

    Visit

Section 05

Research labs and the charity

Research infrastructure and the registered charity for MSK regeneration.

  • Research MSK

    Research, articles and the clinical evidence behind the treatments — written as research and kept separate from the treatment sites.

    Visit

  • MSK Computer Vision Lab

    Founder and Director (since 2021).

    Sleaford-based lab pioneering computer vision and AI in musculoskeletal health: markerless motion capture, deep learning, applied ML.

  • MFO Life Sciences Lab

    Founder and Principal Investigator (since 2025).

    Grantham-based lab exploring regenerative medicine and the interaction between physical energy modalities and human tissue repair.

  • MSK Regen Foundation (charity)

    Founder and Trustee; Scientific Committee Chair.

    Charity (Charity Registration Number 1211400) dedicated to public musculoskeletal health, research and education in MSK regeneration.

    Owned by Prof Lee. The Scientific Committee Chair role is therefore not independent.

    Visit

Section 06

Technology platforms and commercial supply

AI, imaging, motion-analysis and digital-consent platforms, plus commercial supply / distribution interests. The most clinically significant disclosure is Actomed, which holds the UK distribution interest in ChondroFiller (manufactured by Meidrix Biomedicals GmbH).

  • MAI Motion®

    Conceived, founded and led the development.

    AI-powered motion capture platform delivering objective biomechanical biomarkers. UKCA / MHRA-registered medical platform; Innovate UK KTP; patent pending.

    Visit

  • onMRI™

    Founder and Strategic Lead. Innovate UK KTP; patent pending.

    AI-driven MRI analysis system converting subjective interpretation into reproducible quantitative biomarkers (cartilage/meniscus segmentation, T2 mapping, low-field MRI compatibility).

  • Consent Plus

    Founder and Project Lead.

    Digital innovation for surgical consent. Won The Health Foundation Innovation Award and was adopted nationally.

    Visit

  • regenOS

    Technology platform / operating system underpinning RegenPhD and recovery work.

  • Actomed

    Founder.

    UK distributor for ChondroFiller, the cartilage-repair material made by Meidrix Biomedicals GmbH.

    Paul has a commercial interest in Actomed as UK distributor for ChondroFiller. Disclosed inline whenever ChondroFiller treatment is discussed.

    Visit

  • STARR

    Single Treatment ACL Regenerative Repair: augmented ligament repair technique pioneered at London Cartilage Clinic.

  • STACi

    Single-stage Tissue-engineered Autologous Cartilage Implantation: single-stage cartilage cell therapy pioneered at London Cartilage Clinic.

Section 07

Recovery and optimisation projects

Non-procedure recovery and optimisation work, kept clearly separate from clinical orthopaedic care.

  • RegenPhD

    Creator.

    Recovery, optimisation and longevity education platform.

    Visit

  • Regen Pod

    Recovery, performance and longevity service. Not a substitute for clinical diagnosis, treatment, surgery, rehabilitation or medical care.

    Visit

  • regenEMS device

    A recovery-focused electrical muscle stimulation (EMS) device used in RegenPhD's recovery programmes.

Section 08

How clinical suitability is separated from commercial interest

Treatment selection for any individual patient is driven by the clinical picture (diagnosis, imaging, examination, comorbidities, function, goals) and not by where a given treatment is delivered or who supplies it. When Professor Lee considers a regenerative or named-procedure option for which he has a commercial interest, that interest is disclosed to the patient as part of the consent process, and an unbiased alternative pathway (including the option of further opinion) is offered as a matter of course.

Where the recommended treatment is provided by an entity Professor Lee does not own (an NHS pathway, another consultant, another provider) it is recommended on the same clinical merits and without preference for owned routes.

Section 09

How to raise a concern

If you have a concern about a specific disclosure on this page, or about how a commercial interest has been managed in your individual clinical care, please get in touch via the work-with-Professor-Lee page. Patient-care complaints relating to clinical episodes are also handled through the formal complaints route of the clinic that provided your care.

Related governance pages

Privacy & Cookies Policy